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S_qy The relationship between diabetes mellitus and cancer risk was investigated using data from an
integrated series of case-control studies conducted in Northern Italy between 1983 and 1992. Cases were 9,991
patents with ncident, histologicly confirmed neoplasms below age 75, incling 181 cancers of the oral
cavity and pharynx, 316 of the oesophagus, 723 of the stomach, 828 of the colon, 498 of the rectum, 320 of
the liver, 58 of the gall bladder, 362 of the panceas, 242 of the larynx, 3,415 of the breast, 726 of the
endometrium, 971 of the ovary, 125 of the prostate, 431 of the bladder, 187 of the kkiney, 208 of the thyroid,
80 Hodgin's lymphomas, 200 non-Hodgkin's lymphomas and 120 multiple myelomas. Controls were 7,834
subjects in hospital for acute, non-neoplastic, non-metabolic, non-hormone-related disorders. A history of
diabetes was reported by 5.1% ofmale and 5.4% of female controls. Significantly elevated relative risks (RRs)
among subjects with diabetes were observed for cancers of the lver [RR = 2.8, 95% confidence interval (CI)
2.0-3.91, pancreas (RR = 2.1, 95% CI 1.5-2.9) and endometrium (RR = 3.4, 95% CI 2.7-4.3). After
allowance for obesity and education as well as age and sex, the RRs were 3.0 for liver, 2.3 for pancreas, and
2.8 for endometrium. Diabetic subjects had no elevated risk for any of the other cancer sites considered, For
lver and endometrial cancer the RRs ireain elevated up to 10 years after dias ofdiabets (RR 2.6 and
2.0 respectively), while the RR for pancreatic cancer decined from 3.2 in the first 5 years after of
diabetes to 2.3 from 5 to 9 years and to 1.3 (95% Cl 0.7-2.3) 10 or more years since dias. This sugsts
that the relationship between dabetes mellitus and lver and endometral cancer is probably real, while that
with pancreatic cancer is compatible with diabetes being an early symptom of the disease, or at least of
preneoplastic ksions.
The possible relationship between diabetes mellitus and
cancer risk has long been discussed (Kessler, 1970, 1971;
Armstrong et al., 1976; Ragozzino et al., 1982; Green &
Hougaard, 1984; O'Mara et al., 1985; Levine et al., 1990;
Moss et al., 1991; Davey Smith et al., 1992), but there is still
a need for quantitative and precise assessment of the risk.
This is not surprising, since several studies were based only
on anecdotal reports, and most prospective studies of
diabetics are based on at most a few hundred cases of all
cancers combined (Armstrong et al., 1976; Ragozzino et al.,
1982; Green & Hougaard, 1984; Levine et al., 1990; Moss et
al., 1991), thus making any precise inference about specific
cancer sites difficult.
The largest data set, and hence the most informative study
from the viewpoint of statistical power, was based on 8,220
male and 6,690 female cancer cases and about 5,000 controls
admitted to the Roswell Park Memorial Institute between
1957 and 1965 (O'Mara et al., 1985). In that study, there was
a significant risk ofendometrial cancer among subjects with a
history of diabetes (relative risk, RR 2.0). Significntly
elevated nsks of kidney and non-melanomatous skin cancers
also emerged in females, but not in males. There was no
significnt excess of pancreatic cancer, which however was
associated with diabetes mellitus in a few other studies (Kess-
ler, 1970; Wynder et al., 1973; Whittemore et al., 1983;
Cuzick & Babiker, 1989).
It is still not clear whether the association between diabetes
and pancreatic cancer, if it exists, implies some aspects of
causality, or whether diabetes is only an epiphenomenon of
pancreatic cancer. If this is the case, diabetes should arise
only shortly before clinical diagnosis of pancreatic cancer.
An association between diabetes and primary liver cancer
has also been reported in some studies (Lawson et al., 1986;
La Vecchia et al., 1990a; Yu et al., 1991), but the evidence is
not yet satisfactory, partly because of difficulties in estab-
lishing a diagnosis ofprimary liver cancer. It would be useful
to understand whether this elevated liver cancer risk also
emerges in comparative terms with the general pattern for
other neoplasms.
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To provide further quantitative information on the issue,
and give a further summary overview of the impact of
diabetes on the risk of cancers of several sites, we consider in
this article data from a case-control study conducted in
Northern Italy.
S and
The data were derived from an ongoing integrated series of
case-control studies, based on a network of teaching and
general hospitals in the Greater Milan area. Recruitment of
cases with cancer of various sites and of the corresponding
controls started between 1983 and 1985, and the present
report includes data collected until December, 1992.
The general design of this investigation has already been
described (Negri et al., 1991), and papers on selected cancer
sites have already included some information on diabetes
(Paramni et al., 1989; Franceschi et al., 1990; La Vecchia et
al., 1990a,b, 1991). Briefly, trained interviewers identified and
questioned cases with cancer of a number of selected sites
and controls admitted to hospital for a wide spectrum of
acute, non-neoplastic, non-metabolic, non-hormone-related
conditions. On average, less than 4% of eligible subjects
(cases and controls) refused to be interviewed. Over 85% of
both cases and controls resided in the same region, Lom-
bardy.
The same scheme, criteria for identification and recruit-
ment of cases and controls and interview setting (in hospital)
was utilised for all the studies considered. All questionnaires
included the same structured section on sociodemographic
factors, general characteristics and habits (such as height,
weight, smoking, alcohol and coffee drinking, etc.), frequency
of consumption of a number of indicator foods and a
problem-oriented medical history. In particular, all question-
naires included the same questions on diabetes mellitus and
age at first diagnosis of the disease. Thus, there was no
difficulty in combining data for the purpose of analysing this
variable.
The cases included in the present analysis were 9,991 sub-
jects below the age of 75 years with histologically confirmed,
incident (i.e. diagnosed during the year preceding the inter-
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view) cancers of oral cavity and pharynx, oesophagus,
stomach, colon, rectum, liver, gall bladder, pancreas, larynx,
breast, endometrium, ovary, prostate, bladder, kidney.
thyroid, Hodgkin's diseases, non-Hodgkin's lymphomas and
multiple myelomas. They were admitted to the National
Cancer Institute, to several university hospitals and to the
Ospedale Maggiore, which includes the four largest teaching
and general hospitals in Milan.
The control group included patients admitted for a wide
spectrum of acute conditions to several specialised university
clinics and to the Ospedale Maggiore of Milan. None of the
patients was admitted for malignant tumours, hormonal or
metabolic conditions or any disease related to long-term
modifications of diet. A history of these conditions, if not
related to the present admission, was not a criterion for
exclusion. A total of 7,834 controls were included. Of these,
32% were admitted for traumatic conditions, 24% had non-
traumatic orthopaedic conditions (such as low back pain and
disc disorders), 21% were admitted for acute non-elective
surgical conditions and 23% had other miscellaneous ill-
nesses, such as ear, nose and throat, skin or dental disorders.
The median age of the comparison group was 53 years, and
the distribution of cases and controls according to sex and
age group is given in Table I.
Data analhsis and control ofconfounding
Odds ratios, as estimators of relative risks (RRs) of various
cancers in subjects with a history of diabetes, together with
their 95% confidence intervals (CIs), were first computed
from data stratified for age in decades and, when required,
sex (Breslow & Day, 1980). Further, for neoplasms directly
associated with diabetes, multiple logistic regression models
were fitted, including terms for education, smoking, body
mass index and other specific risk factors for each disease,
besides age and sex.
Results
Table II gives the distribution of various cancer sites and the
comparison group according to history of diabetes mellitus.
Among the controls, 160 (5.1%) males and 252 (5.4%)
females gave a history of diabetes. Among cases, the highest
proportion ofdiabetes was seen in cases of cancer of the liver
(16.2% of males, 12.3% of females), of the pancreas (14.4%
of males, 9.8% of females), and of the endometrium (20.5%).
The corresponding relative risks are given in Table III.
Significantly elevated risks among subJects with diabetes were
observed for cancers of the liver, with a RR of 3.0 (95% CI
to 2.0-4.4) in males and 2.5 (95% CI 1.3-4.9) in females
and of 2.8 (95% CI 2.0-3.9) in both sexes: cancer of the
pancreas, with a RR of 2.6 (95% CI to 1.8-4.8) for males.
1.4(95% CI 0.8-2.5) for females and of 2.1 (95% CI 1.5-2.9)
for both sexes combined; and of the endometrium. with a
RR of 3.4 (95% CI to 2.7-4.3). Diabetic subjects did not
show elevated nrsks of cancer of the oral cavity and pharynx
(RR = 0.5), oesophagus (RR = 0.8), stomach (RR = 0.6).
colon (RR= 1.1), rectum (RR= 0.9), gall bladder (RR=
1.3), larynx (RR = 1.3), breast (RR = 0.8), ovary (RR = 0.7),
bladder (RR = 0.8), kidney (RR = 0.6), thyroid (RR = 0.9),
Hodgkin's disease (RR= 2.1), non-Hodgkcin's lymphomas
(RR = 0.3) and myeloma (RR = 0.3). For stomach cancer.
non-Hodgkin's lymphoma and myeloma the point estimates
were significantly below unity. After allowance for body mass
index and education, the RR of stomach cancer increased to
0.7, and, like that with myeloma, was of borderline
significance; allowance for these or other possible covariates
(e.g. occupation) did not apparently modify the association
with lymphomas.
The relationship between diabetes mellitus and cancers of
the liver, pancreas and endometrium was further considered
Table H Distribution (and percentage) ofcases ofselected cancer sites
and of controls according to self-reported historv of diabetes. Milan.
Italy. 1983-92
Mfales diabetes Females diabetes
Sites ofcancer No Yes (%0 No Yes (%v
Oral cavity and pharynx 148 4 (2.6) 28 1 (3-5)
Oesophagus 244 14 (5.4) 55 3 (5.2)
Stomach 426 17 (3.8) 266 14 (5.0)
Colon 389 34 (8.0) 378 27 (6.7)
Rectum 267 21 (7.3) 200 10 (4.8)
Liver 197 38 (16.2) 74 11 (12.9)
Gall bladder 25 2 (7.4) 28 3 (9.7)
Pancreas 1% 33 (14.4) 120 13 (9.8)
Larynx 211 20 (8.7) 11 0 (-)
Breast - - 3.276 139 (4.1)
Endometrium - - 577 149 (20.5)
Ovary - - 936 35 (3.6)
Prostate 118 7 (5.6) - -
Bladder 340 21 (5.8) 66 4 (5.7)
Kidney 124 5 (3.9) 56 2 (3.5)
Thyroid 60 3 (4.8) 142 3 (2.1)
Hodgkin's disease 47 2 (4.1) 28 3 (9.7)
Non-Hodgkin's lymphomas 118 1 (0.8) 78 3 (3.7)
Multiple myeloma 59 2 (3.3) 58 1 (1.7)
Controls 2.973 160 (5.1) 4.449 252 (5.4)
Table I Distribution of cases of selected cancer sites and controls according to sex and age. Milan. Italy. 1983-92
Male age groups Female age groups
Sites ofcancer <45 45-54 55-64 65 <45 45-54 55-64 > 65 Total
Oral cavity and pharynx 9 53 64 26 2 7 15 5 181
Oesophagus 13 64 122 59 6 9 24 19 316
Stomach 36 99 163 145 28 54 100 98 723
Colon 34 74 152 163 41 78 143 143 828
Rectum 17 50 119 102 24 31 78 77 498
Liver 22 40 113 60 18 16 27 24 320
Gall bladder 3 4 12 8 2 7 8 14 58
Pancreas 16 62 87 64 8 22 49 54 362
Larynx 10 45 117 59 0 2 5 4 242
Breast - - - - 795 1.036 951 633 3.415
Endometrium - - - - 37 145 294 250 726
Ovary - - - - 200 305 312 154 971
Prostate 1 10 52 62 - - - - 125
Bladder 7 43 159 152 4 6 25 35 431
Kidney 16 22 57 34 8 6 27 17 187
Thyroid 31 15 13 4 80 25 26 14 208
Hodgkin's disease 23 9 11 6 20 5 5 80
Non-Hodgkin's lymphomas 19 26 39 35 18 14 22 27 200
Multiple myeloma 3 12 21 25 5 12 10 32 120
Controls 677 830 961 665 1.087 1.163 1.378 1.073 7.834952 C. LA VECCHIA et al.
after allowance for education, smoking and body mass index,
besides age and sex. The risk estimates for liver (RR = 3.0,
95% CI 2.2-4.2) and pancreas (RR = 2.3, 95% CI 1.7-3.2)
were, if anything, higher after multivariate analysis, whereas
that for endometrial cancer decreased from 3.4 to 2.8 (95%
CI 2.2-3.5). Further models were fitted including specific risk
factors for each neoplasm, i.e. history of hepatitis and cir-
rhosis and alcohol consumption for liver cancer, history of
pancreatitis for pancreatic cancer parity and oetrogen use for
endometrial cancer. The estimated RRs were 3.1 (95% CI
2.2-4.3) for liver cancer, 2.1 (95% CI 1.5-3.0) for pancreas
and 3.0 (95% CI 2.3-3.8) for endometrial cancer.
Age at diagnosis of diabetes is considered in Table IV, in
order to distinguish between type I (insulin-dependent) and
type II (adult-onset) diabetes. Although the limited numbers
of early-onset diabetes preclude any conclusion, for pancreas
and endometrium the relative risk was above unity only for
adult-onset diabetes, while for liver cancer the point estimates
were above unity for both insulin-dependent (early-onset,
though non-significantly) and late-onset diabetes.
Time since diagnosis of diabetes is considered in Table V.
For liver and endometrial cancer, the RRs remained elevated
up to 10 or more years after diagnosis of diabetes, with risk
estimates of 2.6 (95% CI 1.6-4.2) and 2.0 (95% CI 1.4-2.9)
respectively, although these estimates were less than those in
the first 5 years since diagnosis (RR 3.9 for liver, 3.7 for
endometrium). In contrast, for pancreatic cancer the RR
declined from 3.2 in the 5 years since diagnosis to 2.3
between 5 and 9 years and to 1.3 (95% CI 0.7-2.3) 10 or
more years after diagnosis of diabetes.
Diuscsso
The present analysis of the relationship between diabetes
mellitus and the risk of cancer at 19 sites showed no
systematic and generalised excess of cancer risk among sub-
jects with diabetes. Significant associations were, however,
observed for three cancer sites: liver, pancreas and endomet-
num. With respect to pancreatic cancer, however, the
association was no more evident 10 years or more since
diagnosis of diabetes, indicating that it may not be causal.
Diabetics were at apparently decreased nrsk of stomach
cancer, non-Hodgkin's lymphomas and multiple myeloma.
The inverse association with stomach cancer was, at least in
the past, explained by allowance for education and body
mass index, and that with myeloma was of borderline signi-
ficance. No plausible explanation, apart from chance or bias,
is available for the apparent inverse association with non-
Hodgkin's lymphomas, particularly since this observation
finds little support in previous work on the issue (Ragozzino
et al., 1982; O'Mara et al., 1985; Davey Smith et al., 1992).
Of specific interest in this study scheme was the possibility
of systematic comparison of the patterns of risk for different
cancer sites with respect to history of diabetes.
Several of the risk estimates were below unity, and this
may reflect the increased likelihood of diabetics to be admit-
ted also for acute conditions included in the control group of
the present study. The prevalence of diabetes was, however,
consistent across diagnostic categories of the controls (5.3%
surgical, 4.2% orthopaedic, 5.6% others). Further, even if
there is some systematic error in our comparison group, this
is unlikely to be large, since the 5.3% estimate of prevalence
of diabetics is consistent with estimates from national
population-based surveys (ISTAT, 1986). Other possible
sources of bias should be limited, since the hospital-based
setting of this study should be optimal as regards the com-
parability and reliability of the information on disease his-
tory (Kelly et al., 1990). Further, cases and controls were
drawn from comparable catchment areas, and the response
rate was practically complete.
The pattern of risk for pancreatic cancer is compatible
with diabetes being an early sign of the disease - or at least
of preneoplastic pancreatic lesion - but the present data lend
some support to the possibility of a real association between
diabetes and endometrial or liver cancer. For these neo-
plasms, some decline in the relative risk with time since
diagnosis of diabetes was evident, but the risk estimates
remained significant for subjects whose diabetes was diag-
nosed 10 years or more in advance.
Endometrial cancer is strongly associated with obesity, and
the consequent increased serum levels and availability of
unopposed oestrogen (Siiteri, 1978, 1987; Parazzini et al.,
Table IV Estimated relative nrsks (RR)' and 95% confidence interval
(CI) of cancers positively related to diabetes according to age at
diagnosis of diabetes, Milan, Italy, 1983-92
Age at diagnosis ofdiabetes
<40 years > 40 years
Sites ofcancer No.b RR (95% CI) No.b RR (95% CI)
Liver 5 1.9 (0.7-4.9) 44 3.3 (2.3-4.7)
Pancreas 3 1.0 (0.3-3.3) 43 2.5 (1.8-3.6)
Endometrium 3 0.5 (2.0-1.7) 146 3.1 (2.5-4.0)
'Adjusted for sex (when appropriate), age, education, smoking and
body mass index by means of multiple logistic regression. Reference
category: no history of diabetes. bNumber ofcases with diabetes.
Table HI Estimated relative risks (RR)' and 95% confidence intervals (CIs) of selected cancer sites
according to history of diabetes and sex, Milan, Italy, 1983-92
Males Females Total
Sites ofcancer RR (95% CI) RR (95% CI) RR (95% CI}
Oral cavity and pharynx 0.4 (0.2-1.2) NEb 0.5 (0.2-1.1)
Oesophagus 0.9 (0.5-1.5) 0.7 (0.2-2.4) 0.8 (0.5-1.4)
Stomach 0.6* (0.4-1.0) 0.7 (0.4-1.2) 0.6* (0.4-0.9)
Colon 1.2 (0.8-1.8) 1.0 (0.6-1.5) 1.1 (0.8-1.5)
Rectum 1.1 (0.7-1.8) 0.7 (0.3-1.3) 0.9 (0.6-1.3)
Liver 3.0* (2.0-4.4) 2.5* (1.3-4.9) 2.8* (2.0-3.9)
Gall bladder NE NE 1.3 (0.5-3.3)
Pancreas 2.6* (1.8-4.0) 1.4 (0.8-2.5) 2.1* (1.5-2.9)
Larynx 1.4 (0.8-2.3) NE 1.3 (0.8-2.1)
Breast - 0.8 (0.6-1.0) -
Endometrium - 3.4* (2.7-4.3) -
Ovary - 0.7 (0.5-1.0) -
Prostate 0.7 (0.3-1.6) - -
Bladder 0.8 (0.5-1.3) 0.7 (0.3-2.1) 0.8 (0.5-1.2)
Kidney 0.6 (0.2-1.5) 0.5 (0.1-2.0) 0.6 (0.3-1.2)
Thyroid 1.6 (0.5-5.2) 0.7 (0.2-2.1) 0.9 (0.4-2.1)
Hodgkin's disease NE NE 2.1 (0.8-5.5)
Non-Hodgkin's lymphomas 0.1* (0.02-0.8) 0.6 (0.2-1.8) 0.3* (0.1-0.8)
Multiple myeloma 0.5 (0.1-1.9) 0.2 (0.03-1.5) 0.3* (0.1-1.0)
'Adjusted for age and sex (when applicable) by multiple logistic regression. Reference category: no
history of diabetes. bNE, not estimated. *P<0.05.A CASE-CONTROL STUDY OF DIABETES MELLITUS AND CANCER RISK 953
Table V Estimated relative risks (RR)' and 95% confidence intervals (CI) ofcancers positively related
to diabetes according to time since diagnosis ofdiabetes, Milan, Italy, 1983-92
Time since diagnosis ofdiabetes
<5 vears 5-9 iears 10 syears
Sites ofcancer No.b RR 95% CI No." RR 95% CI No.b RR 95% CI
Liver 13 3.9 (2.3-6.5) 9 2.9 (1.4-6.0) 21 2.6 (1.6-4.2)
Pancreas 22 3.2 (2.0-5.2) 10 2.3 (1.1-4.5) 14 1.3 (0.7-2.3)
Endometrium 67 3.7 (2.6-5.3) 32 3.1 (1.9-5.0) 50 2.0 (1.4-2.9)
'Adjusted for sex (when appropriate), age, education, smoking and body mass index by means of
multiple logistic regression. Reference category: no history ofdiabetes. bNumberofcases with diabetes.
1991). Allowance for body mass index, however, only
moderately reduced the relative risk for diabetes, the point
estimates declining from 3.4 to 2.8. This would suggest that
diabetes or some correlates of it (i.e. specific dietary patterns
of diabetics) (Levi et al., 1993) has some independent effect
on endometrial cancer risk (Nyholm et al., 1989).
The association with liver cancer could find some
biological explanation in changes in hepatocellular activity
and, perhaps, mitosis, related to the metabolic alterations in
diabetics. Alternatively, diabetes may be seen as a conse-
quence of impaired liver function. History of hepatitis and
cirrhosis, also associated to the risk of hepatocellular car-
cinoma, could not, however, totally explain the association
(La Vecchia et al., 1990a). Further, the time pattern ofrisk is
mconsistent with this hypothesis, since the liver cancer risk
remained elevated several years after diagnosis of diabetes.
In conclusion, therefore, this integrated series of studies,
while showing no generalised increased cancer nrsk among
diabetics, confirmed an association between diabetes and
endometrial cancer, and further indicated a relationship
between diabetes and liver cancer. A short-term relationship
between diabetes and pancreatic cancer was also observed,
but was consistent with early symptoms of pancreatic disease
being related both to diabetes and pancreatic neoplasm.
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